RxDoctor Payments Data

Rise Perry

Gerontology · Lancaster, PANPI 1588076434

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 32.1% of the total. Among gerontology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,147in general payments, 2019–2025

Across 115 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Johnson & Johnson$884
  • Boston Scientific$354
  • Medtronic$294
  • Bridgebio Pharma, Inc.$145
  • Sanofi$124
  • plus $336 from 6 others

What the payments were for

  • Food & beverage$2,97795%
  • Education$1705%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,147 in reported general payments places this provider in the 90th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$22,274
Medicare patients
139
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban213$230,858
CamzyosMavacamten11$91,713
XareltoRivaroxaban62$69,822
EntrestoSacubitril/Valsartan30$27,549
JardianceEmpagliflozin21$14,914
Dofetilide32$5,954
Metoprolol Succinate200$2,605
Flecainide Acetate65$2,164
Disopyramide Phosphate15$1,467
Bisoprolol Fumarate26$1,201
Mexiletine Hcl22$1,069
SotalolSotalol Hcl28$988
Amiodarone Hcl78$780
ClopidogrelClopidogrel Bisulfate27$710
Metoprolol Tartrate90$632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$70$230,858213 claims
E.r. Squibb & Sons, L.L.C.Camzyos$1,010$91,71311 claims
Johnson & JohnsonXarelto$884$69,82262 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 383 gerontology providers in Pennsylvania.

Other gerontology in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →